An act amending the act of December 14, 1992 (P.L.1116, No.145), entitled "An act providing minimum standards, terms and conditions for the licensing of persons who engage in wholesale distributions in interstate commerce of prescription drugs; and making a repeal," further providing for definitions and for license application.

Summary

The bill adds a new definition for "virtual manufacturer"—a Pennsylvania‑based entity that markets drugs or medical devices without ever holding the physical product in the state. It changes the license application to require only a statement that the company has applied or will apply for FDA approval, and bars the department from demanding FDA approval as a licensing condition. The changes become law 60 days after enactment.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share